Companies that once served primarily local customers now ship their products across the country as the ketamine boom has presented an alluring opportunity. “It’s become the new buzz in this space,” said Jeanine Sinanan-Singh, chief executive of Vitae Industries, which sells a machine that compounding pharmacies can use to produce doses at a faster clip than with other methods.

Read the full article on the New York Times